Longidaze<sup>®</sup>

Longidaze®

International non-proprietary name: bovhyarulonidase azoximer

An advanced sustained release enzyme for combined therapy of connective tissue hyperplasia diseases (adhesion, scarring, or fibrous processes).

Used in gynecology, urology, dermatovenerology, pulmonology, orthopedics, surgery, esthetic medicine, and otolaryngology.

Dosage forms: suppositories, and lyophilizate for solution for infusion.

Go to the website